MedTrace Logo

Treatment of Depression Following Multiple Brain Tests

NCT00296777 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2012-04-27

No results posted yet for this study

Summary

The main purpose of this study is to correlate brain testing with treatment outcome.

Conditions

Interventions

DRUG

Escitalopram

8 weeks: up to 40 mg/day

DRUG

Bupropion

8 weeks: up to 450 mg/day (for patients without history of seizures or risk for developing seizures.

DRUG

Imipramine

8 weeks: up to 300mg/day \*if patient does not have contraindication.

Sponsors & Collaborators

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Jonathan W. Stewart, MD. · New York State Psychiatric Institute - Columbia University Department of Psychiatry

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2007-05-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00296777 on ClinicalTrials.gov